ACXP
Acurx Pharmaceuticals LLC
NASDAQ: ACXP · HEALTHCARE · BIOTECHNOLOGY
$1.03
+0.98% today
Updated 2026-11-04
Market cap
$5.69M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.67
Dividend yield
—
52W range
$1 – $8
Volume
0.1M
WallStSmart proprietary scores
26
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C5.3
Quality
C+3.0
Profitability
D5.0
Valuation
C+3/9
Piotroski F-Score
Weak
-15.1
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →251 stocks currently score above 75
Price targets
Analyst target
$17.00
+1550.49%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
1 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
Insufficient data
Risks
- Piotroski 3/9 — weak financial health
- Altman Z -15.05 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-1.71M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-12.09M | $-14.58M | $-14.10M | $-7.97M | $-2.25M |
| EPS | — | — | — | — | $-2.67 |
| Free cash flow | $-7.54M | $-9.80M | $-10.38M | $-6.79M | $-1.71M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Acurx Pharmaceuticals LLC trades at $1.03. Our Smart Value Score of 26/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of -15.05, it sits in the distress.
Frequently asked questions
What is Acurx Pharmaceuticals LLC's stock price?
Acurx Pharmaceuticals LLC (ACXP) trades at $1.03.
Is Acurx Pharmaceuticals LLC overvalued?
Acurx Pharmaceuticals LLC carries a Smart Value Score of 26/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.
What is the price target of Acurx Pharmaceuticals LLC (ACXP)?
The 12-month analyst consensus target is $17.00, about 1550.5% above the current $1.03. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
Altman Z-Score?
Acurx Pharmaceuticals LLC's Altman Z-Score is -15.05, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-106.92%
Beta-2.05
50D MA$1.30
200D MA$1.98
Shares out0.01B
Float0.01B
Short ratio—
Avg volume0.1M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—